---
category: news
title: "Dyno Therapeutics Closes $100M Series A Financing"
excerpt: "Dyno Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company applying artificial intelligence (AI) to gene therapy, raised $100m in Series A financing"
publishedDateTime: 2021-05-06T12:57:00Z
originalUrl: "https://www.finsmes.com/2021/05/dyno-therapeutics-closes-100m-series-a-financing.html"
webUrl: "https://www.finsmes.com/2021/05/dyno-therapeutics-closes-100m-series-a-financing.html"
type: article
quality: 24
heat: -1
published: false

provider:
  name: finsmes.com
  domain: finsmes.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.finsmes.com/wp-content/uploads/2021/05/dyno.jpg"
    width: 400
    height: 400
    isCached: true

related:
  - title: "Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI‑powered Gene Therapy Platform"
    excerpt: "Dyno is making AAV gene therapies more effective, safer, more manufacturable and applicable to more diseases, and will expand capacity to meet partnership demand CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyno Therapeutics,"
    publishedDateTime: 2021-05-06T12:04:00Z
    webUrl: "https://www.pharmiweb.com/press-release/2021-05-06/dyno-therapeutics-closes-100-million-series-a-financing-led-by-andreessen-horowitz-to-accelerate-ai"
    type: article
    provider:
      name: PharmiWeb
      domain: pharmiweb.com
    quality: 24
    images:
      - url: "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png"
        width: 1200
        height: 448
        isCached: true
  - title: "BRIEF—Dyno Therapeutics raises $100 million for gene therapies"
    excerpt: "AI-driven gene therapy specialist Dyno Therapeutics has raised $100 million in a series A financing led by investment company Andreessen Horowitz. The firm said it would use the money to expand its CapsidMap platform,"
    publishedDateTime: 2021-05-06T15:51:00Z
    webUrl: "https://www.thepharmaletter.com/in-brief/brief-dyno-therapeutics-raises-100-million-for-gene-therapies"
    type: article
    provider:
      name: The Pharma Letter
      domain: thepharmaletter.com
    quality: 19

secured: "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;/hNK8a7QTKGrOAMWWU5P3Q=="
---

